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Summary 
The c-foe serum response element (eRE) forms a ter- 
nary complex with the transcription factors SRF 
(serum response factor) and TCF (ternary complex fac- 
tor). By itself, SRF can mediate transcriptional acti- 
vation induced by serum, lysophosphatidic acid, or 
intracellular activation of heterotrimeric G proteins. 
Activated forms of the Rho family GTPases RhoA, 
Racl, and CDC42Hs also activate transcription via SRF 
and act synergistically at the SRE with signals that 
activate TCF. Functional Rho is required for signaling 
to  SRF by several stimuli, but not by activated 
CDC42Hs or Racl. Activation of the SRF-linked signal- 
ing pathway does not correlate with activation of the 
MAP kinases ERK, SAPK/JNK, or MPK2/p38. Func- 
tional Rho is required for regulated activity of the c-foe 
promoter. These results establish SRF as a nuclear 
target of a novel Rho-mediated signaling pathway. 
Introduction 
The serum response element (SRE) is a regulatory se- 
quence found in many growth factor-regulated promoters 
(reviewed by Treisman, 1990). The SRE binds the ubiqui- 
tous transcription factor SRF (serum response factor; Nor- 
man et al., 1988), which is required for its activity. At the 
c-fos SRE, SRF forms a ternary complex with TCF (ternary 
complex factor), which cannot bind the SRE by itself (Shaw 
et al., 1989). In this complex, TCF, which comprises mem- 
bers of a small family of Ets domain proteins, including 
Elk-l, SAP-l, and SAP-2/ERP/NET, contacts an Ets rec- 
ognition motif adjoining the SRF-binding site (for refer- 
ences see Treisman, 1994). The TCFs regulate SRE activ- 
ity in response to activation of the Ras-Raf-ERK pathway 
(see Treisman, 1994; also Kortenjann et al., 1994), cooper- 
ating with the SRF C-terminal activation domain to activate 
transcription (Hill et al., 1993; Johansen and Prywes, 
1993). 
Although c-fos promoter mutants that cannot bind TCF 
are not responsive to activation of the Ras-Raf-ERK path- 
way, they remain responsive to signals elicited by whole 
serum (Graham and Gilman, 1991). TCF-independent se- 
rum-induced SRE activation is dependent on SRF, but 
does not require a growth factor-regulated phosphoryla- 
tion of the protein at Ser-103 (Hill et al., 1994; Johansen 
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and Prywes, 1994). Regulated transcriptional activation 
by SRF requires that it is bound to DNA via its own DNA- 
binding domain and is blocked by mutations in this domain 
that do not impair DNA binding: this suggests that SRF 
may change conformation upon binding DNA, allowing its 
interaction with a non-TCF "recognition factor" activated 
by serum-induced signals (Hill et al., 1994). A similar 
model has been proposed for activation by MCM1, a Sac- 
charomyces cerevisiae protein that is also involved in tran- 
scriptional regulation in response to extracellula~ signals 
and whose DNA-binding domain is 70% identical to that 
of SRF (Tan and Richmond, 1990; Bruhn and Sprague, 
1994). 
The serum mitogen lysophosphatidic acid (LPA) can 
also activate c-fos promoter mutants that do not bind TCF, 
as can intracellular activation of heterotrimeric G proteins 
by aluminum fluoride ion (AIF4-; Hill and Treisman, submit- 
ted). LPA, which acts via a heterotrimeric G protein-cou- 
pled putative serpentine receptor, activates multiple sig- 
naling pathways that lead to increased Ras-GTP 
formation and ERK activation, and also induce cytoskele- 
tal rearrangements and tyrosine kinase activation (re- 
viewed by Jalink et al., 1994; Moolenaar, 1995). Two ob- 
servations suggest that the latter esponses are mediated 
by Rho, a member of the Ras superfamily of small 
GTPases (Hall, 1994). First, microinjection of activated 
Rho has similar effects to LPA stimulation (Paterson et 
al., 1990; Ridley and Hall, 1992); second, inactivation of 
endogenous Rho proteins by Clostridium botulinum C3 
transferase blocks LPA-induced cytoskeletal rearrange- 
"ments and tyrosine phosphorylation (Ridley and Hall, 
1992; Kumagai et al., 1993). 
In this paper we have analyzed regulated transcription 
by SRF in more detail. We show that functional RhoA is 
required for LPA-, serum-, and AIF4--induced transcrip- 
tional activation by SRF and that tw~ other Rho family 
GTPases, Racl and CDC42Hs, can also potentiate SRF 
activity. These results establish SRF as the target of novel 
nuclear signaling pathways mediated by Rho family 
GTPases. 
Results 
The SRF-Binding Site Responds to Signaling 
Pathways Induced by Serum, LPA, and 
Heterotrimeric G Proteins 
We have shown that c-foe promoter mutants that lack a 
TCF-binding site remain strongly responsive to serum, 
LPA, and AIF4- (Hill and Treisman, submitted). To test 
whether SRF can mediate this response in the absence 
of other c-foe promoter elements, we examined regulation 
of the c-foe derivative 3D.AFOS. Here, thec-fos transcrip- 
tion unit is controlled by a minimal promoter consisting 
of three c-foe-derived SRF-binding sites inserted 5' to a 
Xenopus ,(-actin TATA box (Mohun et al., 1987). This pro- 
moter does not contain an intact TCF-binding consensus 
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Figure 1. The SRF Site-Controlled Reporter 
Gene 3D.AFOS Responds to Only a Subset of 
c-los Inducers 
Cells were transfected with plasmids con- 
taining either the intact c-fos gene (pF711; 
lanes 1-5) or the 3D.AFOS reporter gene 
(lanes 6-20), together with an ,z-globin refer- 
ence plasmid. Inductions were as described 
in Experimental Procedures. Total cell RNA, 
prepared from uninducsd cells (lanes 1,6,11, 
and 16) or after induction with FCS (lanes 2, 
7,12, and 17), TPA (lanes 3 and 8), CSF1 (lanes 
4 and 9), LPA (lanes 5 and 10), AICla (lane 13), 
NaF (lane 14), AIF4- (lane 15), PDGF (lane 18), 
EGF (lane t9), or UV-C (lane 20), was analyzed 
by RNase protection. Protected fragments 
were generated as follows: human c-fos, 287 
nt (mRNA cap to Hincll; exon 1); 3D.AFOS, 
242 nt (Notl o Hincll; exon 1); human ~-globin 
reference, 95 nt 0z-globin initiation codon t  3' 
end; exon 1), mouse c-fos, -60 nt (from par- 
tially protected exon 1). 
sequence and is therefore defective in TCF binding (R. T. 
and J. W., unpublished data). 
The 3D.AFOS reporter or the wild-type human c-fos 
gene were transfected into mouse NIH 3T3 cells express- 
ing the colony-stimulating factor 1 (CSF1) receptor ('1"56 
cells; Roussel et al., 1990), and c-fos RNA synthesis fol- 
lowing various stimuli was monitored by RNase protection. 
Whole serum and LPA induced transcription of both 
genes; in contrast, tetradecanoyl phorbol acetate (TPA) 
and CSF1, which activate the c-fos promoter via TCFI 
failed to activate 3D.AFOS significantly (compare lanes 
1-5 with 6-10 in Figure 1). The 3D.AFOS gene was also 
efficiently activated by AIF4-, produced in situ by the com- 
bination of aluminum chloride and sodium fluoride (Figure 
1, lanes 11-15). We tested three other stimuli that require 
TCF to activate the c-fos promoter: epidermal growth fac- 
tor (EG F), platelet-derived growth factor (PDGF), and ultra- 
violet C (UV-C) irradiation (Graham and Gilman, 1991; 
Sachsenmaier et al., 1994; Hill and Treisman, submitted); 
none of these efficiently activated the 3D.AFOS gene (Fig- 
ure 1, lanes 18-20). Similar esults were obtained in NIH 
3T3 cells (data not shown; see below). These data demon- 
strate that SRF-binding sites are sufficient to activate tran- 
scription in response to serum, LPA, and activation of het- 
erotrimeric G proteins. 
SRF Mediates the Response to Serum, 
LPA, and AIF.- 
To provide direct evidence for the involvement of SRF in 
LPA- and AIF4--induced transcription, we used a pre- 
viously described functional assay for serum-regulated ac- 
tivity of SRF (Hill et al., 1994). This assay measures activity 
of SRE.LP, a mutant c-fos SRE comprising a low affinity 
SRF-binding site with no associated TCF-binding site. In 
transfected cells, endogenous SRF cannot saturate 
SRE.LP, which is therefore inactive; however, overexpres- 
sion of wild-type SRF by a cotransfected expression plas- 
mid is sufficient to restore serum inducibility of SRE.LP 
to - 10% the level observed with the intact c-fos SRE (Hill 
et al., 1994). 
NIH 3T3 cells were transfected with an SRE.LP- 
controlled reporter gene and stimulated with serum, LPA, 
or AIF4-. As a control, we used a reporter controlled by 
SRE.L, a derivative of the c-fos SRE that contains an intact 
high affinity-binding site for SRF, but lacks the TCF- 
binding site (Hill et al., 1994). The SRE.L reporter was 
activated by LPA and AIF,-, although less efficiently than 
by whole serum (Figure 2, left), while, as expected, the 
SRE.LP reporter responded to none of the stimuli (Figure 
2, right). Overexpression of wild-type SRF restored activity 
of SRE.LP to - 10% the activityof SRE.L (Figure 2, right). 
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Figure 2. SRF Activates Transcription i Re- 
sponse to Serum, LPA, and AIF4- 
Cells were transfected with TKCAT reporter 
plasmids controlled by SRE.L (left) or the muta- 
tionally inactivated SRE.LP (right), together 
with expression plasmids producing human 
I~-globin (control) or SRF derivatives, as indi- 
cated. Inductions and quantitation were as de- 
scribed in Experimental Procedures. Data 
shown are average of four qualitatively similar 
independent experiments. The standard devia- 
tions were on average 40% of the means 
shown here. 
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Figure 3. Rho Family Proteins Activate the 
SRE Independently of TCF 
(A) Activation of the SRE by small GTPases. 
Cells were transfected with TKCAT reporter 
plasmids controlled by the wild-type SRE (left) 
or SRE.L (right), together with the indicated 
amounts (in micrograms) of expression plas- 
raids RSV.Ras.R12, EXV.RhoA.V14, EXV.Racl. 
V12, or EXV.CDC42Hs.V12. 
(B) Activation of the TCF Elk-1 by small 
GTPases. Cells were cotransfected with the 
LexA operator-controlled r porter plasmid and 
an expression plasmid producing the LexA- 
Elk-1 fusion protein NLexA.EIkC and with ex- 
pression plasmids producing either Ras.R12, 
RhoA.V14, Rac1.V12, or CDC42Hs.V1~2. The 
data in (A) and (B) are from a representative 
experiment. Similar results were obtained in
four further independent experiments. Induc- 
tions and quantitation were as described in Ex- 
perimental Procedures xcept hat 5% FCS 
was used. 
(C) Diagramatic representation of the promoter 
sequences used and summary of their cognate transcription factors. Closed circle, SRF-binding site; stippled rectangle, TCF-binding site. In SRE.L, 
the TCF-binding site is replaced by a LexA half-operator. Open rectangle, LexA operator. 
Two SRF DNA-binding domain mutants that cannot re- 
store the serum-regulated activity of SRE.LP, SRF-M2 and 
8RF-198/203 (Hill et al., 1994), also failed to restore the 
response of SRE.LP to LPA and AIF4- (Figure 2, right). 
These data demonstrate that in addition to serum, LPA, 
and AIF4- can regulate transcriptional activation by SRF. 
Activated Rho Family GTPases Potentiate 
TCF-Independent Transcription 
We next investigated the roles of signaling molecules acti- 
vated by the LPA receptor. At least some of the effects 
of LPA are mediated by Ras and Rho, small GTPases 
belonging to the Ras superfamily (reviewed by Hall, 1994; 
Jalink et al., 1994; Moolenaar, 1995). We were particularly 
interested to test the involvement of Rho family proteins 
in regulation of SRF activity because these proteins may 
be involved in signaling to the nucleus in the heterotrimeric 
G protein-controlled yeast pheromone pathway (Schultz 
et al., 1995; see Discussion). We therefore tested whether 
mutationally activated forms of Ha-Ras and the Rho family 
members RhoA, Racl, and CDC42Hs could activate the 
SRE independently of TCF. 
NIH 3T3 cells were transfected with CAT reporter genes 
controlled by either two copies of the wild-type c-los SRE, 
or its derivative SRE.L, which cannot bind TCF, together 
with expression plasmids producing the activated small 
GTPases Ras.R12, RhoA.V14, Rac1.V12, or CDC42Hs. 
V12. Coexpression of each of the proteins activated the 
wild-type SRE in the absence of growth factor stimulation, 
with an efficiency approaching that of serum stimulation 
in the case of CDC42Hs (Figure 3A, left). In contrast, the 
SRE.L reporter responded only weakly to Ras.R12 but 
consistently exhibited a slightly enhanced response to the 
Rho family proteins (compare left and right panels in Fig- 
ure 3A; the low response of SRE.L to serum stimulation 
in this experiment was not reproducibly observed [Hill et 
al., 1994]). Activation of SRE.L by Rho family proteins, 
serum, and LPA was abolished by an SRE mutation that 
prevents SRF binding (data not shown). 
The data presented above suggest that activation of the 
SRE by Ras.R12 is mediated by TCF, but show that acti- 
vated Rho family members can induce TCF-independent 
SRE activation. To test whether Rho family GTPases can 
also activate TCF, we tested their ability to potentiate tran- 
scriptional activation by NLex.EIkC, a LexA fusion protein 
containing the transcriptional activation domain of the TCF 
Elk-1 (Marais et al., 1993). LPA activates the ERKs via Ras 
(Jalink et al., 1994; Moolenaar, 1995) and can therefore 
potentiate transcriptional activation by NLex.EIkC (M. A. 
Price and R. T., unpublished data; Figure 3B); however, 
although Ras. R12 strongly activated N Lex.EIkC, expres- 
sion of the Rho family proteins did not increase activation 
above background levels, suggesting tha~they do not acti- 
vate the ERKs (Figure 3B). 
We next asked whether the response of the SRE to acti- 
vated Rho family proteins is dependent on SRF, by testing 
the ability of SRF to potentiate the response of the SRE. LP 
reporter described above. For these experiments we con- 
centrated on the RhoA.V14 and CDC42Hs.V12 proteins, 
Table 1. SRF Potentiates SRE Activation by Rho Family Proteins 
CAT Activity" 
Plus Plus Plus 
Stimulus None SRF.WT SRF-M2 SRF-198/203 
None 1.0 1.6 0.6 0.6 
Plus 15% FCS 4.5 33.7 1.7 12.8 
Plus RhoA.V14 17.8 32.7 3.8 14.1 
Plus CDC42Hs.V12 6.5 17.3 1.6 4.8 
a The TKCAT reporter gene, SRE.LP, was cotransfected with the indi- 
cated SRF derivatives. CAT activity was determined relative to the 
uninduced level of reporter alone as t. Data are the average of three 
qualitatively similar independent experiments; tandard eviations 
were on average 39% of the means hown here. 
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Figure 4. Cooperation between SRF and the 
TCF Elk-1 
(A) TCF- and SRF-mediated signals act syner- 
gistically at the SRE. Cells were cotransfected 
with the SRE.L-controlled TKCAT reporter plas- 
mid and expression plasmids producing the 
Elk-1 derivatives NL.EIk or NL.EIk307A, as in- 
dicated. SRF-mediated signaling pathways 
were specifically activated by expression of ei- 
ther RhoA.V14 or CDC42Hs.V12 from EXV ex- 
pression plasmids and TCF-mediated signal- 
ing pathways by expression of ANRaf from 
EXV.ANRaf (Howe et al., 1992). Data shown 
are the average of two qualitatively similar inde- 
pendent experiments; standard deviations 
were on average 25% of the means shown 
here. 
(B) Schematic interpretation f the data. The 
SRF-binding site of the SRE is indicated by a 
stippled rectangle and the mutated TCF- 
binding site by a nondescript shape. SRF is 
shown as a pair of circles; NL.EIk, which can 
bind the mutated TCF site, as a rounded 
square; and NL.EIk307A, which is refractory 
to activation, as a rectangle. Uninduced factors 
are depicted as unshaded, partially activated 
are shown by light gray shading, and strongly 
activated factors are shown by dark gray shad- 
ing. Arrows indicate activation. 
since these activate the SRE more strongly than Racl .V12; 
results are shown in Table 1. In the presence of the acti- 
vated RhoA.V14 and CDC42Hs.V12 proteins, the SRE. LP 
reporter etained significant activity (see Discussion). This 
activity was potentiated by wild-type SRF, but notby the 
SRF mutants SRF-M2 and SRF-198/203; as observed with 
the responses to serum, LPA, and AIF4-, SRF-M2 expres- 
sion suppressed the activity of SRF. LP below backgound 
levels (Table 1 ; see Figure 2). Taken together, these data 
indicate that activated Rho family proteins can potentiate 
transcriptional activation by SRF. 
TCF- and SRF-Linked Signaling Pathways Activate 
the SRE Synergistically 
Three observations suggest that activation of the intact 
c-los SRE involves activation of both TCF-linked and SRF- 
linked signaling pathways. First, although mutations that 
block binding of TCF to the c-los SRE do not block induc- 
tion by serum, binding of a transcriptionally incompetent 
TCF mutant can interfere with serum-induced transcrip- 
tion (Hill et al., 1994). Second, endogenous TCF bound 
at the wild-type SRE consistently appears to have an inhib- 
itory effect on transcriptional activation induced by acti- 
vated Rho family proteins. Third, SRF DNA-binding do- 
main mutations impair activity of the SRF-TCF ternary 
complex as well as TCF-independent activity (Hill et al., 
1994). To investigate these phenomena further, we ex- 
ploited our ability to activate TCF- and SRF-linked signal- 
ing pathways independently. 
We previously constructed an altered specificity deriva- 
tive of the TCF Elk-l, NL.EIk, that can form a ternary com- 
plex with SRF at SRE.L, which cannot bind endogenous 
TCF (Hill et al., 1993, 1994). We used this protein to modu- 
late the level of TCF present at SRE.L. As a control, we 
used NL.EIk307A, an NL.EIk derivative that lacks the 
C-terminal activation domain (Hill et al., 1993; Marais et 
al., 1993). To activate TCF- and SRF-linked signaling path- 
ways, we coexpressed either the activated Raf derivative, 
ANRaf (Howe et al., 1992), or the activated Rho family 
proteins RhoA.V14 or CDC42Hs.V12. The data are shown 
in Figure 4A and summarized in Figure 4B. 
As shown above, activity of SRE.L was strongly stimu- 
lated by coexpression of activated RhoA or CDC42Hs, but 
not by ANRaf, which also did not significantly potentiate 
activation by the Rho family proteins (Figure 4A, gray 
bars). The NL.EIk protein potentiated the response of 
SRE.L to ANRaf, but inhibited its response to RhoA.V14 
and CDC42Hs.V12; howeverTANRaf and either RhoA.V14 
or CDC42Hs.V12 together synergistically activated SRE. L 
(Figure 4A, closed bars). This phenomenon required the 
Elk-1 C-terminal activation domain: whereas cotransfec- 
tion of NL.EIk307A also inhibited the response of SRE.L 
to RhoA.V14 or CDC42Hs.V12, it could not potentiate the 
response of SRE.L to ANRaf, even in the presence of 
activated Rho family proteins (Figure 4A, open bars). 
Taken together, these results suggest a model in which 
TCF- and SRF-linked signaling pathways cooperate to ac- 
tivate the c-fos SRE (Figure 4B; see Discussion). 
SRF and ERK Activation Can Be Dissociated 
We next investigated whether activation of SRF-linked sig- 
naling pathways requires ERK activation. In Rat1 and 
COS-7 cells, LPA induces ERK activation via G~, which is 
sensitive to pertussis toxin (Jalink et al., 1994; Moolenaar, 
1995). We used an immune complex kinase assay to test 
whether ERK activation in NIH 3T3 cells expressing 
epitope-tagged ERK2 is also sensitive to pertussis toxin. 
Pretreatment with 100 ng/ml pertussis toxin reduced LPA- 
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Figure 5. Activation of Known MAP Kinases Is 
Not Sufficient for SRF-Linked Signaling 
(A) Serum- and LPA-induced SRF-linked sig- 
naling is pertussis toxin insensitive. (Left) Cells 
were transfected with pEXV.ERK2.tag, which 
produces 9E 10 epitope-tagged ERK2, together 
with either EFplink (control) or the C3 trans- 
ferase expression plasmid EFC3. EXV expres- 
sion plasmids producing ANRaf or EF expres- 
sion plasmids producing RhoA.V14, Racl. 
V12, or CDC42Hs.V12 were included as indi- 
cated. The numbers under each lane are fold 
inductions over basal activity and are the aver- 
ages of two independent experiments. (Right) 
Cells were transfected with the SRE.L-con- 
trolled TKCAT reporter gene. The d~ta are the 
average of two qualitatively similar ndepen- 
dent experiments; standard eviations were on 
average 34% of the means shown here. P r- 
tussis toxin (PTx) treatment and inductions with 
FCS (5°/o), LPA, and TPA were as indicated. 
(B) SRF-linked signaling does not correlate 
with MEK, SAPK/JNK, nor MPK2/p38 activa- 
tion. Cells were either transfected with the 
SRE.L-controlled TKCAT reporter gene (left) or left untransfected (right). Data shown on the left are averaged from up to seven qualitatively similar 
independent experiments; standard deviations were on average 540/0 of the means shown here. Kinase activity in MEK-, SAPKa/~/~'-, and MPK2/ 
p38-specific immunoprecipitates was measured using GST.EIkC, GST. JunN, and GST.SAP2C substrates, respectively (right). Extracts were 
prepared 15 rain following induction, except for UV-C, which was after 1 hr (similar results were obtained when UV-C-i duced SAPK/JNK activity 
was measured 10 or 30 min following stimulation). The numbers below the kinase assays are fold inductions over baseline a d are the averages 
of two independent experiments. 
induced ERK2 activation to background levels and signifi- 
cant!y impaired serum-induced ERK2 activation (Figure 
5A, left panel, lanes 2, 3, 5, and 6); similar results were 
obtained using an ERK immunoblotting assay (data not 
shown). However, pertussis toxin treatment inhibited nei- 
ther serum- or LPA-induced activation of SRE.L (Figure 
5A, right), nor accumulation of 3D.AFOS RNA (data not 
shown). Thus, serum- and LPA-induced activation f SRF 
does not appear to be mediated by G~ or to require ERK2 
activation. Moreover, activated Rho family proteins did not 
potentiate ERK2 activity in the immune complex kinase 
assay (Figure 5A, left panel, lanes 8-13). These results 
suggest that ERK activation is neither necessary nor suffi- 
cient for activation of SRF. 
SRF Activation Does Not Correlate with Activation 
of MEK, SAPK/JNK, or MPK2/p38 in NIH 3T3 cells 
In addition to the ERKs, the related MAP kinases SAPK/ 
JNK and MPK2/p38 can be independently regulated by 
extracellular signals (reviewed by Cooper, 1994). To as- 
sess whether activation of any of these enzymes corre- 
lates with induction of TCF-independent SRE activity, we 
tested the ability of agents reported to activate one or more 
of these pathways to activate SRE.L and analyzed kinase 
activity in parallel using immune complex kinase assays. 
In addition to the stimuli used so far, we also tested activa- 
tion of the SRE.L reporter by osmotic shock and arsenite, 
which activate MPK2/p38 and SAPK/JNK. All the stimuli 
that activated SRE.L also activated MEK, the ERK2- 
activating enzyme; however, even though TPA strongly 
activated MEK, it did not activate SRE.L (Figure 5B). Simi- 
lar results were obtained with PDGF, EGF, and CSF1 (data 
not shown; see Figure 1). Although UV-C irradiation 
strongly activated SAPK/JNK and MPK2/p38, it did not 
activate SRE.L (Figure 5B) or 3D.AFOS (see Figure 1). 
Serum- and LPA-induced activation f SRE.L activity was 
also unaffected by treatment of cells with a pyridinyl imid- 
azole M PK2/p38-specific inhibitor (data not shown). Taken 
together, these data strongly suggest that none of these 
MAP kinases is sufficient o mediate SRF-linked signaling 
pathways. 
Effect of Inhibitors on SRF-Linked Signaling 
We used specific inhibitors to test whether signaling mole- 
cules previously implicated in signaling by serum, LPA, 
and Rho family proteins are involved in SRF.linked signal- 
ing. Wortmannin (1 I~M) and rapamycin (0.4 p.g/ml), which, 
respectively, block LPA-induced phosphatidylinositide 
3-kinase (PI3K) and serum-induced p70-$6 kinase acti- 
vation in Swiss 3T3 cells, did not significantly affect reg- 
ulation of SRE.L (data not shown). Thapsigargin pre- 
treatment, which depletes endoplasmic Ca 2÷ and blocks 
LPA- or seru m-induced Ca 2+ mobilization, had little effect 
alone on SRE.L activity or 3D.AFOS RNA accumulation, 
but led to superinduction of the reporters when combined 
with LPA or serum induction (data not shown). This sug- 
gests that elevation of cytoplasmic Ca 2+ concentration is 
not a prerequisite for activation of the SRF-linked signaling 
pathway, but may potentiate its activity. 
In Swiss 3T3 cells, LPA induces rapid Rho-dependent 
tyrosine phosphorylations associated with the formation 
of focal adhesions and p60 ~c kinase activation, which are 
inhibited upon disruption of the cytoskeleton by cytocha- 
lasin D (Jalink et al., 1994; Moolenaar, 1995; Ridley and 
Hall, 1994; Seufferlein and Rozengurt, 1994). Our serum- 
deprived NIH 3T3 cells exhibited a high basal level of 
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Figure 6. Specific Functional Inactivation of 
RhoA by C3 Transferase 
(A) C3 specifically modifies RhoA. Cells were 
transfected with expression plasmids as fol- 
lows: lanes 1, 2, 9, and 10, EFplink vector; 
lanes 3, 4, 11, and 12, EF.RhoA.V14; lanes 5 
and 6, EF.Rac1.V12; lanes 7 and 8, EF. 
CDC42Hs.V12; lanes 13 and 14, EF.RhoA.141; 
lanes 15 and 16, EF.RhoA.V14/141. In lanes 
1-8, 3 p.g of Rho expression plasmid was used; 
in lanes 9-16, 6 ~g. Transfection mixes also 
included either EFplink (odd lanes) or EFC3 
(even lanes). Following maintenance in me- 
dium containing 0.5% FCS for 36 hr, cells were 
lysed directly into SDS-PAGE loading buffer 
and fractionated by SDS-PAGE, and Rho fam- 
ily proteins were detected by immunoblotting 
with 9E10 antibody. 
(B) C3 transferase functionally inactivates 
RhoA. Cells were cotransfected with reporter 
plasmid 3D.ACAT and expression plasmids 
EF.RhoA.V14, EF.Rac1.V12, EF.CDC42Hs. 
V12, or EF.RhoA.V14/141 together with EFplink 
or EFC3, as indicated. Data shown are the av- 
erage of three qualitatively similar indapendent 
experiments; tandard eviations were on av- 
erage 48% of the means hown here. In these 
expedments and those in Figures 7 and 6, the 
EFI~ promoter was used to control expression 
of Rho family proteins, since the SV40 early 
enhancer/promoter is partially inhibited by C3 
transferase xpression. 
p125 FAK and paxillin tyrosine phosphorylation, which was 
not ii~Creased by LPA or serum stimulation. Tyrosine phos- 
phorylation was abolished following a 40 min treatment 
with 2 I~M cytocholasin D, which itself strongly activated 
SRE.L, but had no effect on the ability of LPA or serum 
to induce c-fos transcription (data not shown). Finally, al- 
though the tyrosine kinase inhibitor tyrphostin 25 (50 p,M) 
led to an -2-fold reduction in SRE.L activity, the Src- 
directed inhibitor herbimycin A (2 I~M) actually increased 
SRE.L activity 2- to 3-fold. Taken together, these results 
suggest that SRF-linked signaling requires neither tyro- 
sine phosphorylation of focal adhesion-associated pro- 
teins nor the integrity of the actin cytoskeleton. 
Rho Is Required for TCF-Independent SRE 
Activation by Extracellular Signals 
The experiments described so far do not address whether 
RhoA, Racl, and CDC42Hs are intermediates on serum-, 
LPA-, or AIF4--induced signaling pathways to the SRE or 
whether they activate independent signaling pathways 
that converge at the SRE. C. botulinum C3 transferase 
specifically ADP-ribosylates Rho at Asn-41, thereby inacti- 
vating it (Paterson et al., 1990; Hall, 1994). We therefore 
used intracellular C3 transferase xpression to test whether 
functional Rho is required for the response to extracellular 
signals. 
We first assessed the specificity of C3 transferase action 
by SDS-polyacrylamide gel electrophoresis (SDS-PAG E) 
(Paterson et al., 1990). Expression of C3 led to decreased 
electrophoretic mobility of coexpressed epitope-tagged 
RhoA.V14, but not he Racl .V12 or CDC42Hs.V12 deriva- 
tives (Figure 6A, lanes 1-8); modification of RhoA required 
Asn-41, since mutation of this residue prevented the C3- 
induced mobility shift (Figure 6A, lanes 9-16). As a more 
rigorous test of C3 specificity, we tested its ability to inhibit 
Rho family-mediated activation of SRF-linked signaling 
pathways in vivo. Preliminary experiments demonstrated 
a slight sensitivity of the TK promoter used in our reporters 
to C3 expression, and so for these experiments, we used 
3D.ACAT, a reporter gene analogous to 3D.AFOS (Mohun 
et al., 1987). Activation of 3D.ACAT by RhoA.V14 was 
substantially inhibited by C3 coexpression, while activa- 
tion by Racl .V12 and CDC42Hs.V12 was unaffected (Fig- 
ure 6B). As expected, activation of 3D.ACAT by the ADP- 
ribosylation-resistant RhoA derivative RhoA.V14/141 was 
also unaffected by C3 expression (Figure 6B, lanes 9 and 
10). Thus, C3 activity is Rho-specific in vivo, and activation 
of SRF-linked signaling pathways by activated Racl and 
CDC42Hs does not require functional Rho. 
We next used C3 expression to test whether endoge- 
nous Rho is required for regulated activity of the 3D.ACAT 
reporter. As a control, we also tested the effect of C3 on 
activation of the TCF Elk.l, using the GAL4-derived fusion 
protein GaI.EIkC (Marais et al., 1993). Expression of C3 
completely inhibited activation of 3D.ACAT, both by serum 
and other stimuli tested (Figu re 7A). In contrast, C3 expres- 
sion had relatively little effect on activation of GaI.EIkC by 
serum, osmotic shock, and activated Ras, and it reduced 
activation by PDGF, TPA, and AIF4- -2-fold (compare 
Figures 7A and 7B). Surprisingly, C3 expression blocked 
activation of GaI.EIkC by arsenite and LpA, suggesting 
that in our NIH 3T3 cells, as in Swiss 3T3 cells, ERK2 
activation by these stimuli is Rho dependent (Figure 7B; 
Kumagai et al., 1993). We confirmed directly that LPA- 
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Figure 7. C3 Transferase Specifically Blocks SRF-Linked Signaling 
Pathways 
Cells were transfected with either the reporter plasmid 3D.ACAT (A) or 
the reporter plasmid pGsEIb.CAT (GalOP) together with an expression 
plasmid that produces the Elk-1 TCF-derived activator GaI.EIkC (B). 
Transfection mixes also included either EFplink or EFC3. Inductions 
were as indicated (see Experimental Procedures). The expression 
plasmid RSV.Ras.R12 was used for Ras.R12 stimulation. Data shown 
are the average of two qualitatively similar independent experiments; 
standard eviations were on average 37% of the means shown here. 
The values for Ras activation in (B) were 1276 (no C3) and 1436 
(with C3). 
and serum-induced ERK activation is indeed Rho depen- 
dent, by use of the immune complex kinase assay with 
extracts from cells expressing both epitope-tagged ERK2 
and C3 transferase (see Figure 5A, lanes 2, 4, 5, and 7; 
data not shown). 
These data suggest that multiple extracellular signals 
activate an SRF-iinked signaling pathway that is depen- 
dent on a functional Rho protein. In contrast, activated 
forms of Racl or CDC42Hs signal to the SRE indepen- 
dently of Rho, suggesting that at least two SRF-linked 
signaling pathways therefore converge on the SRE (see 
Discussion). 
RhoA Can Mediate Serum-, LPA-, and AIF4--Induced 
Signaling to SRF 
It remained possible that the effects of C3 transferase 
upon signaling to the SRE observed in the preceding ex- 
periments were due to inactivation of substrates other than 
Rho. To confirm directly that a specific Rho family protein 
can mediate serum-, LPA-, and AIF4--induced signals, we 
exploited the fact that the RhoA.141 mutant is refractory 
to modification by C3 transferase (see Figure 6A; Paterson 
et al., 1990). As shown above, C3 expression completely 
inhibited activation of the SRE-controlled reporter gene 
by serum, LPA, or AIF4-. However, coexpression of the 
ADP-ribosylation-resistant RhoA.141 protein effectively 
restored the response to serum and AIF4- and partially 
restored the LPA response (Figure 8). Expression of 
RhoA.141 in the absence of coexpressed C3 potentiated 
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120 
p, 
O, 
I 0~5% FCS 
I l l  + 15% FCS 
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Figure 6. RhoA Can Mediate SRF-Linked Signaling~ 
Cells were transfected with reporter plasmid 3D.ACAT. Transfection 
mixes also included either EFplink (control) or EFC3 with RhoA.141 
expression plasmid EF.RhoA.141 or EFplink as indicated. Inductions 
were as indicated (see Experimental Procedures). Data shown are 
average of two qualitatively similar independent experiments. The 
standard deviations were on average 17% of the means shown here. 
both the basal level of 3D.ACAT activity and the response 
to each stimulus (Figure 8). These results demonstrate 
that a specific Rho isotype, RhoA, can mediate signaling 
to the SRE by these stimuli. 
Rho- and Ras-Dependent Signals Interact at the 
c-fos Promoter 
Previous studies have shown that activation of the c-los 
promoter by many different stimuli can be inhibited by 
expression of the interfering Ras derivative Ras.N17. Al- 
though we have shown that a constitutively active Ras 
mutant does not efficiently activate the SRE independently 
of TCF, it remained possible that Ras.N17 might inhibit 
operation of the SRF-linked signaling pathway. To test this 
and to confirm that functional Rho activity is required for 
the rapid response of the SRE to extracellular stimuli, we 
used RNase protection to investigate the effect of Ras. N 17 
or C3 transferase expression oQ induction of 3D.AFOS 
transcription. Serum- and LPA-induced transcription of the 
3D.AFOS gene was effectively abolished by C3 coexpres- 
sion, in agreement with the CAT assays, while the constitu- 
tive expression of the ~-globin reference gene was unaf- 
fected (Figure 9, lanes 1-6). However, activation of the 
3D.AFOS reporter was also impaired by Ras.N17 (Figure 
9, lanes 7-9; Ras.N17 reproducibly inhibits activity of the 
a-globin reference gene in NI H 3T3 cells). Thus, functional 
Ras also appears required for SRF-linked signaling, even 
though activated Ras is not sufficient for activation (see 
Discussion). 
Finally, we used C3 transferase to test whether func- 
tional Rho is required for regulated c-los transcription. We 
examined induction by two kinds of stimulus: those that 
activate the c-los SRE via both SRF- and TCF-linked sig- 
naling pathways, such as serum and LPA, or those that 
activate only TCF-linked signaling pathways, such as TPA 
and polypeptide growth factors (see also Hill and Treis- 
man, submitted). Inactivation of endogenous Rho by C3 
transferase expression dramatically reduced induction of 
the gene in response to all the stimuli (compare lanes 10- 
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Figure 9. Functional Rho Is Required for c-fos 
Induction 
Cells were transfected with plasmids con- 
taining either the 3D.AFOS reporter gene 
(lanes 1-9) or the intact c-los gene (pF711; 
lanes 10-19), together with the ~-globin refer- 
ence plasmid MLVa118 and either EFC3 (5 I~g; 
lanes 4-6 and 15-19) or the Ras.N17 expres- 
sion plasmid RSV.Ras.N17 (lanes 7-9) as indi- 
cated. Inductions were as described in Experi- 
mental Procedures. Total cell RNA, prepared 
from uninduced cells(lanes 1,4, 7, 10, and 15) 
or following a 30 rain treatment with FCS (15o, 
lanes 2, 5, and 8; 5O/o, lanes 11 and 16), LPA 
(lanes 3, 6, 9, 12, and 17), TPA (lanes 13 and 
18), or PDGF (lanes 14 and 19) was~analyzed 
by RNase protection as described in the legend 
to Figure 1. Note that Ras.N17 expression re- 
producibly reduces activity of the MLV-con- 
trolled reference gene in these experiments. 
14 with lanes 15-19 in Figure 9). Functional Rho protein 
is therefore required for efficient activation of the c-fos 
promoter in response to multiple stimuli. 
, r  
Discussion 
We have demonstrated that serum, LPA, and the hetero- 
trimeric G protein activator AIF4- can activate the c-fos 
SRE. This activation requires SRF, but does not depend 
on formation of the ternary complex with TCF. Activation of 
SRF by serum-, LPA-, AIF4--, and stress-induced pathways 
requires a member of the Rho family of small GTPases 
and can be mediated by RhoA. Activated mutant forms 
of the other Rho family proteins Racl and CDC42Hs can 
also activate SRF independently ofTCF, but do not require 
RhoA to do so, suggesting that at least two signaling path- 
ways controlled by Rho family proteins target SRF. Activa- 
tion of known MAP kinase pathways does not correlate 
with activation of SRF. Two kinds of signaling pathway 
converge at the SRE: one links TCF activity to the Ras- 
induced ERK activation, while the other links SRF activity 
to Rho family induced signals (see Figure 10A). 
Several previousobservations have suggested that Rho 
family GTPases have roles in signaling to the nucleus and 
the control of cell proliferation (for discussion see Boguski 
and McCormick, 1993; Hall, 1994; Qiu et al., 1995). Our 
data establish that Rho family proteins are involved in 
transmission of growth factor and mitogen signals to the 
nucleus and establish SRF as a target for such signals. 
Signaling Pathways That Activate SRF 
A variety of stimuli can activate transcription via SRF inde- 
pendently of TCF, including LPA, AIF4-, serum, osmotic 
shock, and arsenite treatment. LPA is presumed to act via 
a heterotrimeric G protein-coupled serpentine receptor 
(Jalink et al., 1994; Moolenaar, 1995), and heterotrimeric 
G proteins are activated by AIF4- in the absence of ligand 
binding (Bigay et al., 1985). Moreover, mutational analysis 
of c-fos promoter egulation shows that these agents can 
activate a signaling pathway distinct from those activated 
by receptor-tyrosine kinases (Hill and Treisman, submit- 
ted). We propose that serum and LPA, which is abundant 
in serum, activate the same signaling pathway (see Figure 
10); the comparatively stronger response of the SRE to 
whole serum may reflect the activity of other serum albu- 
min-associated lipids (for discussion see Moolenaar, 
1995). It remains unclear at which point the serum-induced 
signal converges with those induced by osmotic shock 
and arsenite, as the sensors for these stress responses 
remain uncharacterized. 
Three lines of evidence implicate RhoA in the SRF- 
linked signaling pathways discussed above. First, the acti- 
vated form of RhoA can activate SRF in the absence of 
TCF. Second, expression of C. botulinum C3 transferase, 
which we demonstrated to inactivate Rho specifically, 
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Figure 10. Comparison of Signaling Pathways to the c-los SRE with 
the S. cerevisiae Pheromone Signaling Pathway 
(A) Signaling pathways to the c-fos SRE. (B) Pheromone signaling 
pathway to MCM1. Rectangles, Ras superfamily proteins; rounded 
squares, MAP kinase cascades. The putative recognition factor (Hill 
et al., 1994) that interacts with the SRF DNA-binding domain is indi- 
cated by a circled X. For discussion see text. 
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blocked activation of the SRE by these stimuli. Expression 
of C3 transferase in transfection experiments did not in- 
hibit activation of other reporters, demonstrating that the 
observed effects are specific consequences of Rho inacti- 
vation. Third, when a C3-resistant RhoA derivative was 
coexpressed with C3 transferase, serum-, LPA-, and AIF4-- 
induced signaling to SRF was restored, showing that RhoA 
is sufficient for signal transduction and that the C3 target 
is indeed Rho. This result also shows that C3 does not 
inhibit the responses to extracellular signals by affecting 
receptor activity or G protein activation. 
Our work also implicates the Rho family proteins Racl 
and CDC42Hs in signaling to SRF. However, it is not clear 
whether these proteins both activate the same pathway. 
They do not appear involved in LPA- and serum-induced 
SRE activation because expression of dominant negative 
versions of these molecules analogous to the Ras.N17 
mutant (Ridley et al., 1992), did not affect these responses 
(our unpublished data). Moreover, SRE activation by 
Rac1.V12 and CDC42Hs.V12 was not sensitive to C3 
transferase. As will be discussed below, these proteins 
may therefore be involved in a parallel signaling path- 
way(s) to the SRE (Figure 10). 
How Do Rho Family Proteins Signal 
°~to the Nucleus? 
Recent studies have indicated that small GTPases can 
act in linked cascades (reviewed by Chant and Stowers, 
1995).Jn mammalian cells, studies of the roles of small 
GTPases in the assembly of actin-based structures sug- 
gest that CDC42Hs can activate Racl, which in turn can 
activate RhoA, while Ras activation can also lead to activa- 
tion of Racl and RhoA (Ridley and Hall, 1992; Ridley et 
al., 1992; Kozma et al., 1995; Nobes and Hall, 1995). In 
contrast, two observations uggest that activation of SRF- 
linked signaling pathways does not involve cascades of 
this type. First, activation of SRF-linked signaling by 
CDC42Hs and Racl is not dependent on functional Rho; 
second, activated Ras does not activate SRF-linked sig- 
naling efficiently, even at levels that efficiently activate 
transcription by the TCF EIk-l. This apparent paradox 
might arise because the levels of activated small GTPases 
produced in our transfections, while sufficient o activate 
signaling pathways to the nucleus, are insufficient for acti- 
vation of the next GTPase in the cascade. However, we 
cannot rule out the possibility that SRF activation by acti- 
vated CDC42Hs and Racl may arise from promiscuous 
activation of nuclear signaling as a consequence of their 
overexpression. Identification of an extracellular stimulus 
that can activate SRF-linked signaling independently of 
Rho would help clarify this issue. For example, it is clear 
that both SRE activity and c-los expression can be potenti- 
ated following disruption of the cytoskeleton (Zambetti et 
al., 1991), and it will be interesting to investigate the role 
of Rho family small GTPases in this process. 
It is likely that serum- and LPA-induced tyrosine phos- 
phorylation of focal adhesion-associated proteins such as 
paxillin and p125 FAK and cytoskeletal changes (Ridley and 
Hall, 1994; Seufferlein and Rozengurt, 1994) are not pre- 
requisites for activation of SRF-linked signaling pathways. 
In our NIH 3T3 cells, which are serum deprived rather than 
quiescent, tyrosine phosphorylation of p125 F^ K and paxUlin 
is maximal and is not further increased by serum or LPA 
stimulation. Moreover, disruption of the cytoskeleton by 
cytochalasin D treatment, which reduces p125 FAK and pax- 
illin tyrosine phosphorylation to background levels, itself 
strongly activates an SRF-linked signaling pathway and 
does not inhibit activation of c-los transcription by LPA or 
serum. 
As yet we have been unable to correlate activation of 
a particular kinase with activation of the SRF-linked signal- 
ing pathway. ERK2 activation appears neither necessary 
nor sufficient: TPA activates ERK2 but not the SRF:linked 
pathway, and, conversely, pertussis toxin blocks LPA- 
induced ERK2 activation and impairs that by serum with- 
out affecting activation of SRF. Similiarly, activation of the 
SAPKs/JNKs and MPK2/p38 is strongly induced by UV 
irradiation but not sufficient o activate SRF-linked signal- 
ing pathways. Thus, although recent studies show that the 
SAPKs/JNKs can be activated by both G protein-coupled 
receptors (Coso et al., 1995a) and a Racl-mediated signal- 
ing pathway (Coso et al., 1995b [this issue of Cell]; Minden 
et al., 1995 [this issue of Cell]), SAPKs/JNKs are not suffi- 
cient for activation of SRF. We also found that wortmannin 
and rapamycin, which inhibit LPA-induced PI3K activation 
and serum-induced p70-$6 kinase' activation, respec- 
tively, have no effect on LPA- or serum-induced SRF acti- 
vation. 
How, then, are Rho family-mediated signals transmitted 
to the SRE? An attractive idea, prompted by analogy with 
pheromone signaling in S. cerevisiae, is that the effector 
molecules for the proteins are related to the recently de- 
scribed p21-activated kinase (PAK) kinase family (Manser 
et al., 1994; see Figure 10). These serine/threonine ki- 
nases, of which the prototype appears to be the S. cere- 
visiae STE20 protein, are activated by interaction with 
GTP-bound CDC42Hs or Racl. As yet, no Rho-specific 
PAK-related cDNAs have been cloned, although a 70 kDa 
candidate protein has been identified (Manser et al., 1994). 
According to this view, Rho-, CDC42Hs-, and Racl-medi- 
ated signaling pathways to SRF would converge at some 
point downstream of Rho, either via a common PAK-type 
kinase or via a common signaling molecule further down- 
stream. 
How Is SRF Activity Regulated? 
We and others previously obtained data suggesting that 
serum-regulated SRF activity requires the intact DNA- 
bound SRF DNA-binding domain (Hill et al., 1994; Jo- 
hansen and Prywes, 1994). Mutations in the SRF DNA- 
binding domain that do not block DNA binding impair both 
the ability of SRF to mediate TCF-independent ranscrip- 
tional regulation and regulation in the context of the SRF- 
TCF ternary complex. We proposed that serum-induced 
signals target a recognition factor, distinct from TCF, that 
only interacts with the DNA-bound SRF DNAobinding do- 
main (Hill et al., 1994). Our data establish that the putative 
recognition factor is a potential substrate for Rho family- 
mediated signals. We found that an SRE mutant, SRE.LP, 
which contains a low affinity SRF-binding site and which 
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is consequently not responsive to serum stimulation, does 
retain significant activity in the presence of activated Rho 
family proteins, which can be further potentiated by over- 
expression of SRF. Perhaps the increased basal activity 
of SRE.LP in the presence of activated Rho family proteins 
reflects the continuous presence of active recognition fac- 
tor, which might facilitate binding of SRF to the low affinity 
SRE.LP site. We are currently developing methods for the 
identification of the putative recognition factor. 
Our data show that TCF-linked and SRF-Iin ked signaling 
pathways can cooperate to activate the c-fos SRE. When 
both TCF and SRF are simultaneously activated, by stimu- 
lation with activated Raf and Rho family proteins, respec- 
tively, SRE activation is much more efficient than with 
either stimulus alone. However, the presence of inactive 
TCF at the SRE interferes with Rho-induced activation. 
Thus, at SREs at which the ternary complex forms, effi- 
cient activation requires activation of both SRF- and TCF- 
linked signal pathways. This may explain the otherwise 
puzzling observation that although c-fos promoter mutants 
that cannot bind TCF remain serum inducible, their activity 
can be partially blocked by expression of a transcription- 
ally incompetent TCF mutant that can bind the SRE yet 
cannot be activated in response to signals (Hill et al., 
1994). It is therefore possible that agents that trigger only 
SRF-linked signaling pathways will induce only a subset 
of SRE-containing genes. 
We also found that the basal activity of the SRE in serum- 
deprived cells is dependent on Rho; moreover, basal SRF 
activity could also be potentiated by overexpression of 
functional RhoA. If basal activity in SRF-linked signaling 
pathways is necessary for efficient function of the ternary 
complex, this might explain why c-fos activation, even by 
stimuli that do not efficiently stimulate the RhoA-linked 
signal pathway, is still sensitive to inactivation of Rho. In- 
terestingly, SRF apparently acts constitutively toactivate 
several muscle-specific promoters in concert with myo- 
genic factors (Sartorelli et al., 1990). We are currently test- 
ing the idea that background signal in the Rho pathway 
may be responsible for "constitutive" SRF activity, which 
is somehow potentiated by myogenic factors. 
Interactions between Ras- and Rho-Dependent 
Signaling Pathways 
Several observations uggest that Ras- and Rho-mediated 
signaling pathways may be mutually dependent, in the 
sense that although constitutive activation of Ras (or Rho) 
may not be sufficient to activate aparticular signaling path- 
way, activity of that pathway can be blocked by expression 
of the dominant interfering Ras derivative Ras.N17 (or in- 
activation of Rho by C3 transferase). For example, acti- 
vated Ras is not sufficient to activate SRF-lin ked signaling, 
yet expression of Ras.N17 inhibits activation of the SRF- 
linked pathway by extracellular stimuli that act through 
Rho. Similarly, although activated RhoA does not activate 
ERKs or TCF in our NIH 3T3 cells, inactivation of RhoA 
by C3 transferase blocks LPA-induced activation of ERK2, 
which is mediated by Ras. Finally, functional Rho is re- 
quired for optimal activation of the c-fos gene in response 
to many different stimuli, including those that do not di- 
rectly potentiate the activity of SRF-linked signaling path- 
ways, such as PDGF and TPA. 
We envisage two kinds of explanation for such cross- 
talk. First, it might reflect the activation by serum and LPA 
of a signaling molecule common to both pathways, such 
as a guanine nucleotide exchange factor (GEF): indeed, 
several GEFs with activity against both Ras and Rho family 
proteins have been described, and both Ras.N17 and 
ADP-ribosylated Rho proteins sequester GEFs (see Bo- 
guski and McCormick, 1993; Paterson et al., 1990). Ac- 
cording to this view, inhibitory effects of Ras.N17 could 
either be physiologically significant or arise as an artifact of 
GEF titration. Alternatively, cross-talk might arise because 
one pathway contains a component whose acti{,ity is indi- 
rectly dependent on basal activity in the other pathway, 
as is seen in the Rho dependence of PDGF-induced phos- 
pholipid breakdown, which arises because Rho is required 
for 4,5-PIP2 synthesis (Chong et al., 1994). As mentioned 
above, if the activity of the SRF-TCF ternary complex is 
dependent on basal activity of SRF-linked signaling path- 
ways, activation of c-fos by stimuli such as TPA or polypep- 
tide growth factors, which activate TCF, would also be 
sensitive to inactivation of Rho. Clearly, more work needs 
to be done to resolve these issues. 
Relationship to the S. cerevisiae 
Pheromone Pathway 
There are intriguing potential parallels between the SRF- 
linked signaling pathway described here and the mating 
pheromone-induced pathway in S. cerevisiae (reviewed 
by Schultz et al., 1995; Figure 10). Mating pheromone also 
binds to a serpentine receptor: signaling tothe nucleus 
is initiated by the 137 complex of the GPA1/STE4/STE18 
heterotrimeric G protein, which indirectly leads to activa- 
tion of the STE11-STE7-KSS1/FUS3 MAP kinase cas- 
cade. Two observations suggest that this pathwa.y may 
involve a Rho family protein. First, STE20, the kinase that 
controls activation of the MAP kinase cascade, is a homo- 
log of the metazoan PAK kinases, which are regulated by 
Racl and CDC42Hs; apparently, STE20 can also bind 
CDC42Hs (Manser et al., 1994). Second, loss-of-function 
mutations in a yeast Rho-GAP cause consititutive activa- 
tion of the pheromone pathway, suggesting that a Rho 
family protein can activate the pathway (see Schultz et al., 
1995). Pheromone signals activate STE12, a transcription 
factor that activates transcription either autonomously or 
via transcription factor complexes with the SRF-related 
protein MCM1 (Ammerer, 1990; Yuan et al., 1993; Bruhn 
and Sprague, 1994). STE12 is not obviously structurally 
related to TCF, and no metazoan counterparts have yet 
been reported. It is tempting to speculate that the SRF- 
linked signaling pathway found in mammalian cells may 
be more closely related to the evolutionarily ancient yeast 
pheromone pathway than has previously been thought. 
Experimental Procedures 
Plasmids 
All DNA manipulations were carried out by standard techniques, and 
the plasmid structures were verified by sequencing. 
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Reporter Genes 
The following plasmids were as described: pF711 (Traisman, 1985); 
3D.ACAT and 3D.AFOS (Mohun et al., 1987); pSVK~ (Treisman et al., 
1983); pGsElb.CAT (Marais et al., 1993); TKCAT reporter plasmids 
containing two copies of the c-fos SRE, SRE.L (Hill et al., 1993), 
SRE.LP (Hill et al., 1994), or the LexA operator (Marais et al., 1993). 
MLVa118 comprises the human al-globin coding sequences from 
~SVHS~118 (Treisman et al., 1983) inserted into MLVplink (Dalton 
and Treisman, 1992). 
'i:he SRE sequences present in the reporters are as follows. Linker 
sequences are lowercase, SRF sites bolded, Ets motif underlined, and 
LexA half-site italicized: 3D.ACAT and 3D.AFOS, aattGGATGTCCA- 
TATTAGGACATCT; SRE.W'I', ctag.AGGATGTCCATATTAGGACAT- 
CT; SRE.L, ctagATGTACTGTATGTCCATATTAGGACATCT; SRE.LP, 
ctagATGTACTGTATGTACATATTAGTACATCT. 
Ras and Rho Family Expression Plasmids 
All Rho family proteins were expressed as N-terminally 9E10 epitope- 
tagged derivatives. EXV.Racl.V12 and EXV.Racl .V 12/N 17 (Ridley et 
al., 1992) and EXV.RhoA.V14 (Paterson et al., 1990) were as de- 
scribed. EXV.CDC42Hs.N17 and EXV.CDC42Hs.V12 are analogous 
to EXV.RhoA.V14.9E10-tagged Rho family coding sequences were 
removed from EXV plasmids and inserted into EFplink, a vector analo- 
gous to M LVplink (Dalton and Treisman, 1992) but containing the EF1 ~x 
promoter (R. Marais, personal communication). EF.RhoA.141 and 
EF,RhoA.V14/141 were constructed using PCR with appropriate oligo- 
nucleotides. RSV.Ras.N17 and RSV.Ras.R12, derivatives of RSV- 
plink, express human Ha-Ras.N17 and Ras.R12 (Hill and Treisman, 
submitted). 
Other Plasmids 
EFC3 expresses the N-terminally 9E10 spitope-tagged C3 transferase 
coding sequence (nucleotides 1-780; EMBL accession number 
X51464). The following have been described: MLV.SRF-M2, MLV. 
NL.EIk, MLV.NL.EIk307A, MLV.1281~ (Hill et al., 1993), MLV.SRF, and 
MLV.SRF-198/203 (Hill et al., 1994); MLV.NLex.EIkC, MLV.GaI.EIkC 
(Marais et al., 1993); GST.c-Jun(1-194) (Bannister st al., 1993); 
GST.SAP2C (Price et al., 1995); EXV.ERK2.tag and EXV.ANRaf 
(Howe et al., 1992). 
Gene Expression Analysis 
Cell culture, transfections, and gene expression assays were as de- 
scribed previously (Hill et al., 1993; Hill et al., 1994). The experiments 
in Figures 1 and 9 used T56 cells (Roussel et al. 1990); other experi- 
ments used NIH 3T3 cells. The following amounts of plasmid were 
used: 10 p.g of pF711 or 3D.AFOS, 3 p.g of ~-globin plasmids, 10 I.tg 
of RSV.Ras.N17, 4 p.g of CAT reporters, 0.3 p.g of SRF expression 
plasmids, 0.1 p,g of MLV.NL.EIk or MLV,NL.EIk307A, 0.25 p.g of 
MLV.NLex.EIkC or MLV.GaI.EIkC, 1 p,g or 3 p,g of small GTPase ex- 
pression plasmids, 2 p,g of EFC3, 2 p.g of EXV.ANRaf, and 5 p.g of 
EXV.ERK2.tag for kinase assays. The amounts of DNA transfected 
in each experiment were kept constant (generally, 8 p~g) by adding 
control plasmids MLV128~ or EFplink as appropriate. Following trans- 
fection, cells were maintained for 36 hr in medium containing 0.5% 
fetal calf serum (FCS), before induction, which was for 8 hr for CAT 
assays, 30 rain for RNase protection assays, and (unless indicated 
otherwise) 15 rain for kinase assays. Unless otherwise stated, CAT 
assays were quantified taking the serum-induced level of the appro- 
priate reporter system as 100. 
Inductions 
Unless otherwise stated, inductions were as follows: FCS, 15%; LPA, 
10 p.M; TPA, 50 ng/ml; CSF1, 107 ng (200 U)/ml; AICI3, 100 I~M; NaF, 
10 mM; AIF4-, 10 mM NaF plus 100 I~M AICIs; human PDGF-BB, 25 
ng/ml; mouse EGF, 50 ng/ml; UV-C, 50 Jim2; D(-)-sorbitol (osmotic 
shock), 0.5 M in DMEM; sodium arsenite, 0.5 mM. For inductions with 
D(-)-sorbitol, sodium arsenite, NaF, AICIs, or AIF4-, 2 ml of medium 
was first removed from the cells and maintained at 37°C; following a 
45 rain treatment with inducer, cells were washed with PBSA, the 2 
ml medium replaced, and incubation continued at 37°C for a further 
7.25 hr. For UV-C inductions, cells under PBSA were irradiated by a 
germicidal amp for 25 s; the medium was then replaced, and the cells 
were incubated at 37°C for appropriate times. Inhibitor pretreatments 
were as follows: pertussis toxin, 18 hr; tyrphostin 25 or herbimycin, 
15 hr; thapsigargin, wortmannin, or rapamycin, 30 rain; cytochalasin 
D, 40 min. 
Other Methods 
MEK assays were as according to the protocol of D. Schoenwasser 
and P. Parker (see Livingstone et al., 1995); SAPK/JNK, MPK2/p38, 
and 9E10 ERK2 assays were essentially by the method of J. Kyriakis 
and J. Woodgett (personal communication). Expression of GST fusion 
proteins, SDS-PAGE, and immunoblotting were by standard methods. 
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